Saturday, July 10, 2021

Antibiotic-loaded microneedles show promise against MRSA


Microneedle patches have shown promise in the delivery of antibiotics locally to the skin, raising the prospects of being able to treat infections without subjecting patients to systemic therapy.

Writing in the journal Advanced Materials Technologies, researchers at Sweden’s Karolinska Institutet describe the use of microneedles loaded with the antibiotic vancomycin to treat methicillin‐resistant Staphylococcus aureus (MRSA) skin infections in preclinical tests. The approach offers several potential benefits over the systemic administration of antibiotics.    

Local administration of vancomycin could spare patients from the side effects associated with intravenous delivery of the antibiotic. When given intravenously, a high dose must be used to ensure enough antibiotic gets to the targeted bacteria, but concentrations in the skin are still fairly low. The injection of vancomycin to treat skin infections therefore raises the risk of drug resistance. 

Working with skin from piglets and humans, the Karolinska researchers showed vancomycin‐loaded microneedle arrays can overcome the natural limitations of the antibiotic in topical applications. The antibiotic was delivered into the skin and significantly reduced the population of MRSA bacteria. 

The early success has encouraged the researchers to further develop the technology, including by evaluating the performance of the vancomycin‐loaded microneedles in animal models of MRSA infection such as humanized mouse models. The studies will build the case for potentially trying to translate the technology to the clinic. 

“If this drug delivery device reaches the clinics, it has the capacity to transform the way skin infections from potentially lethal bacteria are treated with drastic improvements in the quality of life of patients,” Karolinska’s Georgios Sotiriou, Ph.D., the last author of the study, said in a statement.

The researchers used a water‐soluble polymer to facilitate effective drug release in the skin, as well as a water‐insoluble polymer layer designed to facilitate precise drug dosage formulation.



Source link

Stay Connected

1,605FansLike
11,000FollowersFollow
342FollowersFollow
775FollowersFollow

Latest Articles

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...

Telangana caps Covid treatment charges in private hospitals

Hyderabad: The government of Telangana on Wednesday issued orders fixing treatment and investigation charges for Covid-19 in private hospitals.The state government, which had capped...